Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?

The ventilation–perfusion mismatch can't explain the high P(aCO(2))–P(ETCO(2)) gap in the setting of COVID-19 induced hypoxaemia and cannot be considered as the sole pathophysiological basis for the treatment in the early stage of COVID-19 https://bit.ly/3BKmGxJ

Detalles Bibliográficos
Autores principales: Harutyunyan, Gurgen, Benítez Bermejo, Rosa Isabel, Harutyunyan, Varsenik, Harutyunyan, Garnik, Sánchez Gimeno, Andrés, Cherkezyan, Artur, Petrosyan, Spartak, Gnuni, Anatoli, Soghomonyan, Suren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724909/
https://www.ncbi.nlm.nih.gov/pubmed/36130788
http://dx.doi.org/10.1183/16000617.0138-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724909/
https://www.ncbi.nlm.nih.gov/pubmed/36130788
http://dx.doi.org/10.1183/16000617.0138-2022

Ejemplares similares